All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
PLIANT THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: PLRX

Business Address

260 LITTLEFIELD AVENUE

SOUTH SAN FRANCISCO , CA US 94080

Mailing Address

260 LITTLEFIELD AVENUE

SOUTH SAN FRANCISCO , CA US 94080
Phone Number: 650-481-6770 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $114,297,000.00 $63,234,000.00 $57,679,000.00 $54,951,000.00 $102,527,000.00 $33,685,000.00 $44,617,000.00 $25,070,000.00 $32,545,000.00 $51,665,000.00 $45,231,000.00 $35,193,000.00 $50,819,000.00 $50,882,000.00 $55,224,000.00 $178,461,000.00 -- $85,807,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- $1,580,000.00 $3,297,000.00 $1,983,000.00 $1,482,000.00 $4,989,000.00 $1,249,000.00 $1,998,000.00 $1,610,000.00 $1,830,000.00 $2,174,000.00 $9,279,000.00 $7,131,000.00 $3,599,000.00 -- $7,052,000.00 -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $7,509,000.00 $11,257,000.00 $10,640,000.00 $8,885,000.00 $7,533,000.00 $7,058,000.00 $4,159,000.00 $4,857,000.00 $5,751,000.00 $6,764,000.00 $5,847,000.00 $4,825,000.00 $4,180,000.00 $4,498,000.00 $6,515,000.00 $8,173,000.00 -- $1,742,000.00 -- -- -- --
Total Current Assets $489,898,000.00 $505,502,000.00 $534,335,000.00 $565,701,000.00 $588,227,000.00 $340,311,000.00 $365,965,000.00 $173,526,000.00 $185,363,000.00 $209,441,000.00 $228,584,000.00 $250,719,000.00 $270,537,000.00 $290,754,000.00 $307,729,000.00 $324,323,000.00 -- $111,900,000.00 -- -- -- --
Property Plant and Equipement $5,605,000.00 $3,567,000.00 $3,969,000.00 $4,332,000.00 $4,197,000.00 $4,486,000.00 $4,799,000.00 $4,534,000.00 $4,738,000.00 $4,606,000.00 $4,706,000.00 $4,367,000.00 $4,266,000.00 $4,321,000.00 $4,144,000.00 $4,029,000.00 -- $4,079,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $392,000.00 $392,000.00 $392,000.00 $672,000.00 $644,000.00 $394,000.00 $397,000.00 $913,000.00 $835,000.00 $838,000.00 $831,000.00 $630,000.00 $451,000.00 $451,000.00 $451,000.00 $451,000.00 -- $3,085,000.00 -- -- -- --
Total Assets $521,605,000.00 $512,154,000.00 $540,464,000.00 $574,891,000.00 $597,881,000.00 $350,613,000.00 $377,181,000.00 $184,619,000.00 $197,022,000.00 $221,215,000.00 $234,121,000.00 $255,716,000.00 $275,254,000.00 $295,526,000.00 $312,324,000.00 $328,803,000.00 -- $119,064,000.00 -- -- -- --
Accounts Payable $7,327,000.00 $4,531,000.00 $3,360,000.00 $2,310,000.00 $1,419,000.00 $1,580,000.00 $3,206,000.00 $3,116,000.00 $4,684,000.00 $2,971,000.00 $2,605,000.00 $2,764,000.00 $2,886,000.00 $2,023,000.00 $3,140,000.00 $2,483,000.00 -- $1,250,000.00 -- -- -- --
Accrued Liabilities $5,868,000.00 $10,219,000.00 $8,310,000.00 $6,762,000.00 -- -- $20,306,000.00 $17,395,000.00 $11,626,000.00 $11,991,000.00 $10,320,000.00 $8,168,000.00 $7,364,000.00 $9,576,000.00 $7,886,000.00 $9,553,000.00 -- $6,922,000.00 -- -- -- --
Total Current Liabilities $84,273,000.00 $38,578,000.00 $37,416,000.00 $41,826,000.00 $35,961,000.00 $37,271,000.00 $40,187,000.00 $36,831,000.00 $23,229,000.00 $22,156,000.00 $13,681,000.00 $11,736,000.00 $11,085,000.00 $12,465,000.00 $11,978,000.00 $12,987,000.00 -- $9,084,000.00 -- -- -- --
Long Term Debt $30,002,000.00 $10,054,000.00 $10,021,000.00 $9,988,000.00 $9,958,000.00 $9,929,000.00 $9,900,000.00 $9,871,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $984,518,000.00 $972,973,000.00 $963,588,000.00 $952,452,000.00 $939,205,000.00 $653,707,000.00 $642,795,000.00 $421,781,000.00 $417,931,000.00 $414,348,000.00 $411,037,000.00 $407,522,000.00 $404,868,000.00 $400,918,000.00 $399,162,000.00 $398,110,000.00 -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-489,000.00 $345,000.00 $-1,907,000.00 $-2,241,000.00 $-1,331,000.00 $-1,958,000.00 $-2,454,000.00 $-1,259,000.00 $-950,000.00 $-201,000.00 $-40,000.00 $-30,000.00 $-18,000.00 $-32,000.00 $-18,000.00 $-30,000.00 -- $-1,000.00 -- -- -- --
Accumulated Deficit $-546,703,000.00 $-499,748,000.00 $-458,639,000.00 $-417,152,000.00 $-375,960,000.00 $-338,412,000.00 $-303,352,000.00 $-272,737,000.00 $-243,191,000.00 $-215,091,000.00 $-190,560,000.00 $-163,515,000.00 $-140,684,000.00 $-117,828,000.00 $-98,801,000.00 $-82,267,000.00 -- $-76,295,000.00 -- -- -- --
Total Stockholders' Equity $437,332,000.00 $473,576,000.00 $503,048,000.00 $533,065,000.00 $561,920,000.00 $313,342,000.00 $336,994,000.00 $147,788,000.00 $173,793,000.00 $199,059,000.00 $220,440,000.00 $243,980,000.00 $264,169,000.00 $283,061,000.00 $300,346,000.00 $315,816,000.00 $-64,751,000.00 $-76,295,000.00 $-116,878,000.00 $-102,739,000.00 $-86,513,000.00 $-71,469,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $521,605,000.00 $512,154,000.00 $540,464,000.00 $574,891,000.00 $597,881,000.00 $350,613,000.00 $377,181,000.00 $184,619,000.00 $197,022,000.00 $221,215,000.00 $234,121,000.00 $255,716,000.00 $275,254,000.00 $295,526,000.00 $312,324,000.00 $328,803,000.00 -- $119,064,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $37,146,000.00 $127,797,000.00 $94,614,000.00 $62,275,000.00 $29,273,000.00 $96,936,000.00 $71,822,000.00 $26,335,000.00 $20,881,000.00 $77,549,000.00 $21,052,000.00 $37,745,000.00 $18,527,000.00 $66,193,000.00 $48,339,000.00 $31,455,000.00 -- $47,353,000.00 $35,626,000.00 $24,847,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $52,392,000.00 $185,725,000.00 $138,688,000.00 $91,003,000.00 $43,427,000.00 $136,885,000.00 $33,429,000.00 $34,631,000.00 $29,460,000.00 $105,107,000.00 $28,723,000.00 $49,786,000.00 $25,093,000.00 $83,462,000.00 $59,981,000.00 $38,506,000.00 -- $58,283,000.00 $43,453,000.00 $30,091,000.00 -- --
Loss from Operations $-52,392,000.00 $-184,145,000.00 $-137,108,000.00 $-89,423,000.00 $-42,095,000.00 $-127,200,000.00 $-89,800,000.00 $-29,642,000.00 $-28,211,000.00 $-97,535,000.00 $-27,113,000.00 $-45,823,000.00 $-22,919,000.00 $-41,645,000.00 $-22,629,000.00 $-5,968,000.00 -- $-1,231,000.00 $-43,453,000.00 $-30,091,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.78 $-2.75 $-0.70 $-1.37 $-0.67 $-2.94 $-0.65 $-0.82 $-0.78 $-2.71 $-0.75 $-1.28 $-0.64 $-1.95 $-1.36 $-1.39 -- $-4.22 $-30.03 $-21.70 -- --
Weighted Average Shares Basic 60,180,921 58,719,083 58,319,608 59,172,869 56,057,603 42,015,908 46,799,058 36,144,944 36,116,440 35,846,421 35,906,303 35,726,393 35,645,205 21,344,236 16,592,746 12,253,943 -- 1,623,358 1,561,242 1,486,109 -- --
Earnings Per Share Diluted $-0.78 $-2.75 $-2.06 $-0.70 $-0.67 $-2.94 $-0.65 $-0.82 $-0.78 $-2.71 $-2.03 $-1.28 $-0.64 $-1.95 $-1.36 $-0.85 -- $-4.22 $-30.03 $-21.70 -- --
Weighted Average Shares Diluted 60,180,921 58,719,083 59,688,451 57,623,842 56,057,603 42,015,908 46,799,058 36,173,135 36,116,440 35,846,421 35,787,022 35,726,393 35,645,205 21,344,236 16,592,746 12,253,943 -- 1,623,358 1,561,242 1,486,109 -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 -- 181,000,000 -- -- -- --
Common Stock Shares Outstanding 60,318,542 59,921,002 59,890,980 59,222,685 58,978,902 48,941,254 48,749,842 36,182,297 36,162,459 36,083,301 35,977,294 35,853,916 35,748,336 35,552,795 35,465,715 35,427,199 -- 1,846,024 -- -- -- --
Common Stock Value $6,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00 $5,000.00 $5,000.00 $3,000.00 $3,000.00 -- $3,000.00 $3,000.00 $3,000.00 -- $3,000.00 $3,000.00 -- $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- 10,000,000 10,000,000 10,000,000 -- -- -- -- 10,000,000 -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 -- -- -- -- -- -- -- -- -- -- -- $0.00 -- -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com